PAMIDRONATE DE SODIUM HOSPIRA 3 mg/ml, concentrate for solution for infusion 5 bottles of 5 ml
Active ingredients: Pamidronate disodium
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusion5 bottles of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PAMIDRONATE DE SODIUM HOSPIRA 3 mg/mL, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 flacon(s) en verre de 5 ml
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Sept 2008
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66152222CIP73816966CIP133400938169669Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PAMIDRONATE DE SODIUMsolution | 3 mg · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.